Top MarketRank™ StocksTop MarketRank™NYSE:DGX Quest Diagnostics (DGX) Stock Price, News & Analysis $151.31 -0.35 (-0.23%) As of 01/17/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends About Quest Diagnostics Stock (NYSE:DGX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Quest Diagnostics alerts:Sign Up Key Stats Today's Range$151.10▼$153.5850-Day Range$150.47▼$164.1952-Week Range$123.04▼$165.32Volume760,037 shsAverage Volume600,221 shsMarket Capitalization$16.89 billionP/E Ratio20.34Dividend Yield1.98%Price Target$172.15Consensus RatingModerate Buy Company OverviewQuest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.Read More… Quest Diagnostics Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks99th Percentile Overall ScoreDGX MarketRank™: Quest Diagnostics scored higher than 99% of companies evaluated by MarketBeat, and ranked 13th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingModerate Buy Consensus RatingQuest Diagnostics has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on 7 buy ratings, 6 hold ratings, and no sell ratings.Amount of Analyst CoverageQuest Diagnostics has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Quest Diagnostics' stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth9.10% Earnings GrowthEarnings for Quest Diagnostics are expected to grow by 9.10% in the coming year, from $8.90 to $9.71 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Quest Diagnostics is 20.34, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 111.80.Price to Earnings Ratio vs. SectorThe P/E ratio of Quest Diagnostics is 20.34, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 89.34.Price to Earnings Growth RatioQuest Diagnostics has a PEG Ratio of 2.37. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioQuest Diagnostics has a P/B Ratio of 2.68. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Quest Diagnostics' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.83% of the float of Quest Diagnostics has been sold short.Short Interest Ratio / Days to CoverQuest Diagnostics has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Quest Diagnostics has recently increased by 6.28%, indicating that investor sentiment is decreasing significantly. Dividend4.2 / 5Dividend StrengthStrong Dividend YieldQuest Diagnostics pays a meaningful dividend of 1.98%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthQuest Diagnostics has been increasing its dividend for 13 years.Dividend CoverageThe dividend payout ratio of Quest Diagnostics is 40.32%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Quest Diagnostics will have a dividend payout ratio of 30.90% next year. This indicates that Quest Diagnostics will be able to sustain or increase its dividend.Read more about Quest Diagnostics' dividend. Sustainability and ESG4.7 / 5Environmental Score-0.62 Percentage of Shares Shorted1.83% of the float of Quest Diagnostics has been sold short.Short Interest Ratio / Days to CoverQuest Diagnostics has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Quest Diagnostics has recently increased by 6.28%, indicating that investor sentiment is decreasing significantly. News and Social Media2.8 / 5News Sentiment1.06 News SentimentQuest Diagnostics has a news sentiment score of 1.06. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 14 news articles for Quest Diagnostics this week, compared to 11 articles on an average week.Search InterestOnly 1 people have searched for DGX on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added Quest Diagnostics to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Quest Diagnostics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,167,741.00 in company stock.Percentage Held by InsidersOnly 0.79% of the stock of Quest Diagnostics is held by insiders.Percentage Held by Institutions88.06% of the stock of Quest Diagnostics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Quest Diagnostics' insider trading history. Receive DGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Quest Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Email Address DGX Stock News HeadlinesQuest Diagnostics (NYSE:DGX) Cut to "Hold" at StockNews.comJanuary 17, 2025 | americanbankingnews.comEarnings Preview: What to Expect From Quest Diagnostics' ReportJanuary 15, 2025 | msn.comDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.January 21, 2025 | Brownstone Research (Ad)FY2025 EPS Forecast for Quest Diagnostics Boosted by AnalystJanuary 14, 2025 | americanbankingnews.comQuest Diagnostics names Adrienne Brott Chief Quality, Regulatory Affairs OfficerJanuary 8, 2025 | markets.businessinsider.comQuest Diagnostics Appoints Adrienne L. Brott as Senior VP and Chief Quality and Regulatory ...January 8, 2025 | gurufocus.comQuest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs OfficerJanuary 8, 2025 | prnewswire.comQuest Diagnostics (NYSE:DGX) Stock Quotes, Forecast and News SummaryJanuary 7, 2025 | benzinga.comSee More Headlines DGX Stock Analysis - Frequently Asked Questions How have DGX shares performed this year? Quest Diagnostics' stock was trading at $150.86 at the beginning of the year. Since then, DGX shares have increased by 0.3% and is now trading at $151.3140. View the best growth stocks for 2025 here. How were Quest Diagnostics' earnings last quarter? Quest Diagnostics Incorporated (NYSE:DGX) issued its quarterly earnings results on Tuesday, October, 22nd. The medical research company reported $2.30 EPS for the quarter, beating the consensus estimate of $2.26 by $0.04. The business's revenue for the quarter was up 8.5% compared to the same quarter last year. Read the conference call transcript. How will Quest Diagnostics' stock buyback program work? Quest Diagnostics' Board of Directors authorized a stock repurchase program on Thursday, February 2nd 2023, which authorizes the company to buy back $1,000,000,000 in outstanding shares, according to EventVestor. This means that the company could buy up to 6% of its shares through open market purchases. Shares buyback programs are generally a sign that the company's board believes its stock is undervalued. Does Quest Diagnostics have any subsidiaries? Quest Diagnostics subsidiaries include these companies: MACL, Blueprint Genetics, PhenoPath Laboratories, ReproSource, California Laboratory Associates, Cleveland HeartLab, Cape Cod Healthcare - Business, and more. When did Quest Diagnostics IPO? Quest Diagnostics (DGX) raised $12 million in an initial public offering on Tuesday, January 7th 2025. The company issued 2,300,000 shares at a price of $4.00-$6.00 per share. Dominari Securities and Revere Securities acted as the underwriters for the IPO. Who are Quest Diagnostics' major shareholders? Quest Diagnostics' top institutional shareholders include Nordea Investment Management AB (0.47%), Wedge Capital Management L L P NC (0.16%), Assenagon Asset Management S.A. (0.12%) and JGP Wealth Management LLC (0.09%). Insiders that own company stock include Stephen H Rusckowski, Catherine T Doherty, Michael E Prevoznik, Michael J Deppe, Timothy M Ring, Vicky B Gregg, Karthik Kuppusamy and Mark E Delaney. View institutional ownership trends. How do I buy shares of Quest Diagnostics? Shares of DGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Quest Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Quest Diagnostics investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Adobe (ADBE), General Electric (GE) and ServiceNow (NOW). Company Calendar Last Earnings10/22/2024Ex-Dividend for 1/29 Dividend1/14/2025Today1/20/2025Dividend Payable1/29/2025Next Earnings (Estimated)1/30/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Medical laboratories Sub-IndustryHealth Care Services Current SymbolNYSE:DGX CUSIP74834L10 CIK1022079 Webwww.questdiagnostics.com Phone(973) 520-2700Fax201-462-4169Employees48,000Year Founded1967Price Target and Rating Average Stock Price Target$172.15 High Stock Price Target$185.00 Low Stock Price Target$155.00 Potential Upside/Downside+13.8%Consensus RatingModerate Buy Rating Score (0-4)2.73 Research Coverage15 Analysts Profitability EPS (Most Recent Fiscal Year)$7.44 Trailing P/E Ratio20.34 Forward P/E Ratio17.00 P/E Growth2.37Net Income$854 million Net Margins8.82% Pretax Margin11.67% Return on Equity15.25% Return on Assets6.92% Debt Debt-to-Equity Ratio0.83 Current Ratio1.25 Quick Ratio1.17 Sales & Book Value Annual Sales$9.25 billion Price / Sales1.83 Cash Flow$12.70 per share Price / Cash Flow11.91 Book Value$56.41 per share Price / Book2.68Miscellaneous Outstanding Shares111,610,000Free Float110,733,000Market Cap$16.89 billion OptionableOptionable Beta0.90 Social Links 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report This page (NYSE:DGX) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quest Diagnostics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Quest Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DGX Stock Alerts